Search
ICON PLC
ICLRAdd to Watchlist
163.565USD
-1.965-1.19%
Close 07-31 16:00（ET）Quotes delayed by 15 min
12.62BMarket Cap
21.91P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of ICON PLC is 7.44, ranking 291 out of 385 in the Biotechnology & Medical Research industry. The average price target is 213.50, with a high of 235.00 and a low of 172.00.
Analyst Rating
Based on
18
analysts
Buy
Current Rating
187.267
Target Price
+5.10%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
ICON PLC
ICLR
18
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is ICON PLC's expected revenue for the next quarter?
ICON PLC's expected revenue is 2.01B.
What is ICON PLC's price target?
Analysts forecast that ICON PLC's price target is USD 213.50, with the highest forecast at USD 235.00 and the lowest forecast at USD 172.00.
How have ICON PLCICLR's recent earnings per share performed?
The market expectation was USD 0.94, while ICON PLCICLR's earnings per share (EPS) for the previous quarter was USD 1.37. EPS for the next quarter is expected at USD 2.68.
What is the analyst rating for ICON PLC?
Based on the ratings of ICON PLC's stock from 18 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.